[9] Retatrutide, being unlicensed in the UK, cannot currently be prescribed through standard NHS pathways
This period marks a key point in the treatment as patients often experience more consistent progress
You may not be a fit if youre pregnant, trying to become pregnant, breastfeeding, have certain gastrointestinal conditions, have a history of specific endocrine cancers, or have other medical factors that make GLP-1 treatment inappropriate
We paid close attention to products with consistent feedback on fading dark spots, smoothing texture, and evening skin tone
Some patients reach their target dose at 5 mg, while others benefit from higher levels
Each one acts as a biological signal, telling tissues, glands, and organs what to do